• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM Back to Search Results
Catalog Number EX060803JL
Device Problems Labelling, Instructions for Use or Training Problem (1318); Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/29/2017
Event Type  malfunction  
Manufacturer Narrative
The device history records are being reviewed.The event is currently under investigation.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant was unable to provide any further patient details to bard.Pma510(k): although this product is not sold in the u.S., this event is being reported under regulation 21cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under # p070014.
 
Event Description
It was reported that a stenting procedure for treatment of an in-stent restenosis of a competitor's stent (size 6 x 80) was performed.After the delivery system of the vascular stent (size 6 x 80 mm) was being advanced to the target site, the physician assessed that the vascular stent was shorter than the implanted competitor's stent.Therefore, stent deployment was discontinued and another stent of the same brand (size 6 x 100) was used to complete the procedure successfully.There was no reported patient injury.
 
Manufacturer Narrative
The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to release for distribution.There is no indication for a manufacturing-related failure.During the evaluation of the returned stent delivery system of a 6 x 80 mm stent, the safety lock slider was found to be in locked position.The stent was found to be loaded in the systemin the correct position.The length of the stent was measured to be 80 mm which matches the specification of this device.Potential contributing factors to the reported event have been evaluated.As the reported issue was found to be an isolated incident, no previous investigations of similar complaints could have been reviewed.In this case, the reported deviation in the stent length with regard to the device labeling could not be confirmed during the evaluation of the returned sample.As no images were provided for evaluation, no further assessment could be performed.In general, comparisons with previously placed stents may lead to inaccurate results due to potential elongation of the previously placed stent.On the basis of the information available and the evaluation of the returned device, a definitive root cause for the reported event could not be determined.The ifu supplied with this device as well as the packaging label sufficiently reference the dimensions of the stent.Regarding stent size selection, the ifu states that the length of the target lesion should be measured to ensure complete covering of the lesion by the stent.The reported application of the treatment of an in-stent restenosis represents an off-label use of the device.According to the ifu, the device is intended for the treatment of symptomatic arterial de-novo or recurrent stenotic or occluded lesions in the native superficial femoral artery and proximal popliteal artery.Updated 'eval code & desc - conclusion 1' due to completion of evaluation.
 
Event Description
It was reported that a stenting procedure for treatment of an in-stent restenosis of a competitor's stent (size 6 x 80) was performed.After the delivery system of the vascular stent (size 6 x 80 mm) was being advanced to the target site, the physician assessed that the vascular stent was shorter than the implanted competitor's stent.Therefore, stent deployment was discontinued and another stent of the same brand (size 6 x 100) was used to complete the procedure successfully.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT SOLO VASCULAR STENT SYSTEM
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG -9681442
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
daniela mueller
wachhausstrasse 6
karlsruhe 76227
GM   76227
0497219445
MDR Report Key6526044
MDR Text Key74019913
Report Number9681442-2017-00157
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2018
Device Catalogue NumberEX060803JL
Device Lot NumberANAP3432
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/26/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received06/29/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-